Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    GENESIS Trial: Motixafortide And G-SCF Prepared Multiple Myeloma Patients for Transplant
    Source: Pixabay.com

    GENESIS Trial: Motixafortide And G-SCF Prepared Multiple Myeloma Patients for Transplant

    It is common practice to treat multiple myeloma patients with a stem cell transplant. In the GENESIS trial, the stem cells were autologous (from the patient’s own peripheral blood or bone…

    Continue Reading GENESIS Trial: Motixafortide And G-SCF Prepared Multiple Myeloma Patients for Transplant
    Compassion Corner: A Patient Almost Died Because of a Doctor’s Lack of Understanding and Compassion
    source: pixabay.com

    Compassion Corner: A Patient Almost Died Because of a Doctor’s Lack of Understanding and Compassion

      Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is…

    Continue Reading Compassion Corner: A Patient Almost Died Because of a Doctor’s Lack of Understanding and Compassion
    Recent Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    https://unsplash.com/photos/8rj4sz9YLCI

    Recent Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    An article in PubMed dated October 8, 2021 outlines immune therapies treating myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) patients. Both cancers are hematologic malignancies that begin in the…

    Continue Reading Recent Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    The Long Road to FDA Approval of Plinabulin and G-CSF to Prevent Chemotherapy Induced Neutropenia

    BeyondSpring Pharmaceuticals has issued a press release announcing that the FDA presented the company with a complete response letter pertaining to its drug plinabulin and granulocyte colony-stimulating factor (G-CSF). The…

    Continue Reading The Long Road to FDA Approval of Plinabulin and G-CSF to Prevent Chemotherapy Induced Neutropenia
    Compassion Corner: Doing What is Best For the Patient May Override a Doctor’s Compassion
    source: pixabay.com

    Compassion Corner: Doing What is Best For the Patient May Override a Doctor’s Compassion

    Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…

    Continue Reading Compassion Corner: Doing What is Best For the Patient May Override a Doctor’s Compassion
    Korean Group’s Successful Experiment to Treat Nonalcoholic Steatohepatitis
    source: pixabay.com

    Korean Group’s Successful Experiment to Treat Nonalcoholic Steatohepatitis

    Nonalcoholic steatohepatitis is a liver disease, causing fat to build up in the liver. The resulting inflammation may lead to liver cancer or cirrhosis (scarring) and possible liver failure. As…

    Continue Reading Korean Group’s Successful Experiment to Treat Nonalcoholic Steatohepatitis
    Compassion Corner: Compassionate Use, Expanded Access Part Two: The Terminology Is Different But the Unmet Need Is the Same
    source: pixabay.com

    Compassion Corner: Compassionate Use, Expanded Access Part Two: The Terminology Is Different But the Unmet Need Is the Same

    Continued From Part One Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering.…

    Continue Reading Compassion Corner: Compassionate Use, Expanded Access Part Two: The Terminology Is Different But the Unmet Need Is the Same
     Two Recent FDA and EMA Approvals Bring Hope to ANCA Associated-Vasculitis Patients
    source: pixabay.com

     Two Recent FDA and EMA Approvals Bring Hope to ANCA Associated-Vasculitis Patients

       ANCA-associated vasculitis (AAV) generally targets two enzymes, myeloperoxidase (MPO) or proteinase 3 (PR3) located in the granules of monocytes and neutrophils. These enzymes play a critical role in the…

    Continue Reading  Two Recent FDA and EMA Approvals Bring Hope to ANCA Associated-Vasculitis Patients